Barclays PLC Harrow Health, Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Barclays PLC holds 52,593 shares of HROW stock, worth $1.93 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

52,593

Previous 52,593 -0.0%

Holding current value

$1.93 Million

Previous $2.37 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$20.85 - $46.47 $823,700 - $1.84 Million	39,506 Added 301.87%	52,593 $2.37 Million
Q2 2024 Aug 14, 2024	SELL	$10.0 - $21.64 $313,110 - $677,570	-31,311 Reduced 70.52%	13,087 $273,000
Q1 2024 May 15, 2024	SELL	$9.3 - $13.23 $106,178 - $151,046	-11,417 Reduced 20.46%	44,398 $588,000
Q4 2023 Feb 15, 2024	BUY	$8.1 - $16.36 $161,603 - $326,398	19,951 Added 55.63%	55,815 $624,000
Q3 2023 Nov 07, 2023	BUY	$14.03 - $22.08 $317,358 - $499,449	22,620 Added 170.79%	35,864 $515,000
Q2 2023 Aug 03, 2023	SELL	$17.37 - $28.08 $321,866 - $520,322	-18,530 Reduced 58.32%	13,244 $252,000
Q1 2023 May 04, 2023	BUY	$13.84 - $21.46 $210,381 - $326,213	15,201 Added 91.72%	31,774 $673,000
Q4 2022 Feb 13, 2023	BUY	$10.28 - $14.78 $133,773 - $192,332	13,013 Added 365.53%	16,573 $244,000
Q3 2022 Nov 03, 2022	BUY	$6.57 - $24.88 $7,181 - $27,193	1,093 Added 44.3%	3,560 $43,000
Q4 2021 Feb 14, 2022	SELL	$8.5 - $12.0 $25,032 - $35,340	-2,945 Reduced 54.42%	2,467 $21,000
Q3 2021 Nov 09, 2021	BUY	$6.99 - $10.6 $20,620 - $31,270	2,950 Added 119.82%	5,412 $49,000
Q2 2021 Aug 13, 2021	BUY	$6.68 - $11.07 $16,446 - $27,254	2,462 New	2,462 $23,000
Q4 2020 Feb 11, 2021	SELL	$4.76 - $6.93 $264,156 - $384,580	-55,495 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$4.71 - $7.36 $29,950 - $46,802	6,359 Added 12.94%	55,495 $310,000
Q2 2020 Aug 12, 2020	BUY	$3.61 - $6.47 $176,016 - $315,464	48,758 Added 12898.94%	49,136 $256,000
Q1 2020 May 13, 2020	BUY	$3.5 - $7.31 $1,323 - $2,763	378 New	378 $1,000
Q4 2019 Feb 10, 2020	SELL	$4.6 - $7.88 $253,216 - $433,770	-55,047 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$4.89 - $8.0 $269,179 - $440,376	55,047 New	55,047 $309,000

Others Institutions Holding HROW

# of Institutions

177

Shares Held

21.4M

Call Options Held

845K

Put Options Held

717K

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $992M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account